WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BBIO

Based on 14 analysts offering 12 month price targets for Bridgebio Pharma Inc

Min Forecast
$49.00-4.8%
Avg Forecast
$66.79+29.76%
Max Forecast
$95.00+84.57%

Should I buy or sell BBIO stock?

Based on 14 analysts offering ratings for Bridgebio Pharma Inc.

Strong Buy
Strong Buy
10 analysts 71.43%
Buy
4 analysts 28.57%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BBIO's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates BBIO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their BBIO stock forecasts and price targets.

BBIO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-15
lockedlocked$00.00+00.00%2025-09-12Find Out Why
lockedlocked$00.00+00.00%2025-09-03
lockedlocked$00.00+00.00%2025-08-06
lockedlocked$00.00+00.00%2025-08-06
Cantor Fitzgerald
Top 2%
99
Strong BuyReiterates$95.00+84.57%2025-07-29
Truist Securities
Bottom 6%
6
Strong BuyInitiates Coverage On$66.00+28.23%2025-07-21
Piper Sandler
Bottom 3%
3
Strong BuyMaintains$68.00+32.12%2025-07-14
Jefferies
Bottom 8%
8
Strong BuyInitiates Coverage On$70.00+36.00%2025-07-14
Citigroup
Top 16%
85
Strong BuyMaintains$67.00+30.17%2025-07-11Find out why

1 of 2

Forecast return on equity

Is BBIO forecast to generate an efficient return?

Company
-37.07%
Industry
131.35%
Market
-50.97%
BBIO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BBIO forecast to generate an efficient return on assets?

Company
61.35%
Industry
47.84%
BBIO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BBIO earnings per share forecast

What is BBIO's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$3.28
Avg 2 year Forecast
-$2.03
Avg 3 year Forecast
$0.26

BBIO revenue forecast

What is BBIO's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$462.1M+95.95%
Avg 2 year Forecast
$815.9M+245.99%
Avg 3 year Forecast
$1.4B+489.89%
BBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BBIO revenue growth forecast

How is BBIO forecast to perform vs Biotechnology companies and vs the US market?

Company
78.93%
Industry
85.89%
Market
10.84%
BBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BBIO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BBIO$51.47$66.79+29.76%Strong Buy
IONS$61.10$67.88+11.10%Buy
ROIV$13.95$17.00+21.86%Strong Buy
MDGL$425.60$508.00+19.36%Strong Buy
BMRN$53.14$95.86+80.39%Strong Buy
View Top Biotech Stocks

Bridgebio Pharma Stock Forecast FAQ

Is Bridgebio Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: BBIO) stock is to Strong Buy BBIO stock.

Out of 14 analysts, 10 (71.43%) are recommending BBIO as a Strong Buy, 4 (28.57%) are recommending BBIO as a Buy, 0 (0%) are recommending BBIO as a Hold, 0 (0%) are recommending BBIO as a Sell, and 0 (0%) are recommending BBIO as a Strong Sell.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.

What is BBIO's earnings growth forecast for 2025-2027?

(NASDAQ: BBIO) Bridgebio Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.27%.

Bridgebio Pharma's earnings in 2025 is -$776,415,000.On average, 11 Wall Street analysts forecast BBIO's earnings for 2025 to be -$627,720,900, with the lowest BBIO earnings forecast at -$739,822,110, and the highest BBIO earnings forecast at -$214,108,724. On average, 11 Wall Street analysts forecast BBIO's earnings for 2026 to be -$387,727,960, with the lowest BBIO earnings forecast at -$594,534,047, and the highest BBIO earnings forecast at -$122,347,843.

In 2027, BBIO is forecast to generate $50,525,836 in earnings, with the lowest earnings forecast at -$237,048,945 and the highest earnings forecast at $370,866,898.

What is BBIO's revenue growth forecast for 2025-2027?

(NASDAQ: BBIO) Bridgebio Pharma's forecast annual revenue growth rate of 78.93% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 85.89%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Bridgebio Pharma's revenue in 2025 is $235,812,000.On average, 7 Wall Street analysts forecast BBIO's revenue for 2025 to be $88,334,568,823, with the lowest BBIO revenue forecast at $83,821,653,949, and the highest BBIO revenue forecast at $96,062,173,260. On average, 8 Wall Street analysts forecast BBIO's revenue for 2026 to be $155,971,132,549, with the lowest BBIO revenue forecast at $130,447,652,074, and the highest BBIO revenue forecast at $214,758,697,394.

In 2027, BBIO is forecast to generate $265,919,403,603 in revenue, with the lowest revenue forecast at $216,383,629,678 and the highest revenue forecast at $341,331,363,892.

What is BBIO's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: BBIO) forecast ROA is 61.35%, which is higher than the forecast US Biotechnology industry average of 47.84%.

What is BBIO's Price Target?

According to 14 Wall Street analysts that have issued a 1 year BBIO price target, the average BBIO price target is $66.79, with the highest BBIO stock price forecast at $95.00 and the lowest BBIO stock price forecast at $49.00.

On average, Wall Street analysts predict that Bridgebio Pharma's share price could reach $66.79 by Sep 15, 2026. The average Bridgebio Pharma stock price prediction forecasts a potential upside of 29.76% from the current BBIO share price of $51.47.

What is BBIO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: BBIO) Bridgebio Pharma's current Earnings Per Share (EPS) is -$4.11. On average, analysts forecast that BBIO's EPS will be -$3.28 for 2025, with the lowest EPS forecast at -$3.87, and the highest EPS forecast at -$1.12. On average, analysts forecast that BBIO's EPS will be -$2.03 for 2026, with the lowest EPS forecast at -$3.11, and the highest EPS forecast at -$0.64. In 2027, BBIO's EPS is forecast to hit $0.26 (min: -$1.24, max: $1.94).

What is BBIO's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: BBIO) forecast ROE is -37.07%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.